Tashiro J, Endo M, Bujo H, Shinomiya M, Morisaki N, Saito Y
Second Department of Internal Medicine, School of Medicine, Chiba University, Japan.
Eur J Clin Invest. 1998 Sep;28(9):712-9. doi: 10.1046/j.1365-2362.1998.00332.x.
In mutations of the low-density lipoprotein (LDL) receptor gene, the defect of internalization is caused by a mutation in the cytoplasmic domain of the receptor linked with exons 17 and 18, and the O-linked sugar domain linked with exon 15 has been speculated not to affect the function of the receptor. Here, we describe a novel mutation of the O-linked sugar domain of the LDL receptor gene, designated familial hypercholesterolaemia (FH)-Mishima with Japanese pedigree, which resembles but still differs from classical defective internalization cases.
LDL metabolism was examined in cultured skin fibroblasts from patients. Immunoprecipitation and immunohistochemical techniques were applied for the detection of the receptor protein size and distribution. Screening of the mutant exon(s) of the LDL receptor gene was performed using the polymerase chain reaction-single-strand conformation polymorphism technique (PCR-SSCP), and sequencing of the mutated alleles was carried out using the dideoxy chain termination method.
LDL-binding activity at 4 degrees C in skin fibroblasts from patients was similar to normal, but that at 37 degrees C with the ligand decreased time dependently and was lost at 6 h, resulting in the defect of internalization and degradation of LDL. The receptor protein on the cell surface was detected at 4 degrees C by IgG-C7, an anti-LDL receptor antibody, but was not detected after incubation with LDL at 37 degrees C. The size of the receptor was 112 kD as determined by immunoprecipitation analysis. A deletion of two nucleotides in exon 15 was detected in the DNA sequence of the LDL receptor gene. The deletion results in a shift of the reading frame after Thr-713 of the mutant and makes a stop codon at amino acid 759.
Deletion of the two nucleotides caused novel amino acid sequences after the O-linked sugar domain, which has the ability of sorting on the cell membrane at 4 degrees C, but not at 37 degrees C in vivo, resulting in the complete cessation of activity of the LDL receptor.
在低密度脂蛋白(LDL)受体基因突变中,内化缺陷是由与外显子17和18相连的受体胞质结构域中的突变引起的,并且推测与外显子15相连的O-连接糖结构域不影响受体功能。在此,我们描述了一种LDL受体基因O-连接糖结构域的新型突变,命名为伴有日本家系的家族性高胆固醇血症(FH)-三岛型,其与经典的内化缺陷病例相似但仍有不同。
检测患者培养的皮肤成纤维细胞中的LDL代谢。应用免疫沉淀和免疫组织化学技术检测受体蛋白的大小和分布。使用聚合酶链反应-单链构象多态性技术(PCR-SSCP)对LDL受体基因的突变外显子进行筛查,并使用双脱氧链终止法对突变等位基因进行测序。
患者皮肤成纤维细胞在4℃时的LDL结合活性与正常相似,但在37℃时与配体结合的活性随时间依赖性降低,6小时后丧失,导致LDL内化和降解缺陷。用抗LDL受体抗体IgG-C7在4℃时可检测到细胞表面的受体蛋白,但在37℃与LDL孵育后未检测到。通过免疫沉淀分析确定受体大小为112kD。在LDL受体基因的DNA序列中检测到外显子15中两个核苷酸的缺失。该缺失导致突变体的Thr-713之后的阅读框移位,并在氨基酸759处产生一个终止密码子。
两个核苷酸的缺失导致O-连接糖结构域之后出现新的氨基酸序列,该结构域在4℃时具有在细胞膜上进行分选的能力,但在体内37℃时则没有,导致LDL受体活性完全丧失。